Similar articles for PMID: 28264852

Year	Number of Results
1996	1
1997	1
2000	1
2001	1
2004	3
2005	1
2006	3
2007	3
2008	2
2010	2
2011	1
2012	1
2015	5
2016	11
2017	6
2018	4
2019	5
2020	3
2021	1
2024	0

1

Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.

Venuto CS, Markatou M, Woolwine-Cunningham Y, Furlage R, Ocque AJ, DiFrancesco R, Dumas EO, Wallace PK, Morse GD, Talal AH. Venuto CS, et al. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02283-16. doi: 10.1128/AAC.02283-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28264852 Free PMC article.

2

Development and validation of a UPLC-MS/MS method for the simultaneous determination of paritaprevir and ritonavir in rat liver.

Ocque AJ, Hagler CE, Difrancesco R, Woolwine-Cunningham Y, Bednasz CJ, Morse GD, Talal AH. Ocque AJ, et al. Bioanalysis. 2016 Jul;8(13):1353-63. doi: 10.4155/bio-2016-0040. Epub 2016 Jun 9. Bioanalysis. 2016. PMID: 27277877 Free PMC article.

3

Clinical Pharmacokinetics of Paritaprevir.

Menon RM, Polepally AR, Khatri A, Awni WM, Dutta S. Menon RM, et al. Clin Pharmacokinet. 2017 Oct;56(10):1125-1137. doi: 10.1007/s40262-017-0520-x. Clin Pharmacokinet. 2017. PMID: 28236252 Review.

4

Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies.

Polepally AR, Mensing S, Khatri A, Beck D, Liu W, Awni WM, Menon RM, Dutta S. Polepally AR, et al. Clin Pharmacokinet. 2016 Sep;55(9):1091-101. doi: 10.1007/s40262-016-0385-4. Clin Pharmacokinet. 2016. PMID: 27000758 Clinical Trial.

5

Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials.

Shuster DL, Menon RM, Ding B, Khatri A, Li H, Cohen E, Jewett M, Cohen DE, Zha J. Shuster DL, et al. Eur J Clin Pharmacol. 2019 Feb;75(2):207-216. doi: 10.1007/s00228-018-2566-6. Epub 2018 Oct 5. Eur J Clin Pharmacol. 2019. PMID: 30291369 Clinical Trial.

6

Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir.

Parker AJ, Houston JB. Parker AJ, et al. Drug Metab Dispos. 2008 Jul;36(7):1375-84. doi: 10.1124/dmd.108.020917. Epub 2008 Apr 21. Drug Metab Dispos. 2008. PMID: 18426953

7

Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.

van Heeswijk RP, Veldkamp AI, Mulder JW, Meenhorst PL, Lange JM, Beijnen JH, Hoetelmans RM. van Heeswijk RP, et al. AIDS. 2000 Jun 16;14(9):F103-10. doi: 10.1097/00002030-200006160-00003. AIDS. 2000. PMID: 10894270 Clinical Trial.

8

Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage.

Talal AH, Dumas EO, Bauer B, Rejman RM, Ocque A, Morse GD, Lucic D, Cloherty GA, King J, Zha J, Zhang H, Cohen DE, Shulman N, Pawlotsky JM, Hézode C. Talal AH, et al. J Infect Dis. 2018 Jan 17;217(3):474-482. doi: 10.1093/infdis/jix495. J Infect Dis. 2018. PMID: 29228392 Free PMC article. Clinical Trial.

9

Fine-Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus Infection.

Gao W, Webber AL, Maxwell J, Anderson M, Caro L, Chung C, Miltenburg AMM, Popa S, Van Dyck K, Wenning L, Mangin E, Fandozzi C, Railkar R, Shire NJ, Fraser I, Howell B, Talal AH, Stoch SA. Gao W, et al. Clin Pharmacol Ther. 2020 Jun;107(6):1325-1333. doi: 10.1002/cpt.1737. Epub 2020 Feb 8. Clin Pharmacol Ther. 2020. PMID: 31868916 Clinical Trial.

10

Metabolism and Disposition of the Hepatitis C Protease Inhibitor Paritaprevir in Humans.

Shen J, Serby M, Reed A, Lee AJ, Zhang X, Marsh K, Khatri A, Menon R, Kavetskaia O, Fischer V. Shen J, et al. Drug Metab Dispos. 2016 Aug;44(8):1164-73. doi: 10.1124/dmd.115.067488. Epub 2016 May 13. Drug Metab Dispos. 2016. PMID: 27179127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

45 results

Results by year